A multi-institutional phase II trial of paclitaxel and carboplatin in the treatment of advanced or recurrent cervical cancer-Reference-Cited by-同舟云学术

A multi-institutional phase II trial of paclitaxel and carboplatin in the treatment of advanced or recurrent cervical cancer

Published:2012-05 Issue:2 Volume:125 Page:307-311
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Kitagawa Ryo,Katsumata Noriyuki,Ando Masashi,Shimizu Chikako,Fujiwara Yasuhiro,Yoshikawa Hiroyuki,Satoh Toyomi,Nakanishi Toru,Ushijima Kimio,Kamura Toshiharu

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference26 articles.

1. The epidemiology of cervical cancer;Franco;Cancer J,2003

2. Guidelines for the treatment of recurrent and metastatic cervical cancer;Friedlander;Oncologist,2002

3. Chemotherapy for stage IVB or recurrent cancer of the uterine cervix;Omura;J Natl Cancer Inst Monogr,1996

4. Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group study;Bonomi;J Clin Oncol,1985

5. The role of chemotherapy in the management of carcinoma of the cervix;Thigpen;Cancer J,2003

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recurrence Pattern of Cervical Cancer Based on the Platinum Sensitivity Concept: A Multi-Institutional Study from the FRANCOGYN Group;Journal of Clinical Medicine;2020-11-12

Clinical Value Of Apatinib As A Salvage Treatment In Patients With Chemo-Refractory Advanced Cervical Cancer

;OncoTargets and Therapy;2019-11

3. Emphasis on Systemic Therapy in Women With Pelvic Bone Metastasis at Time of Diagnosis of Cervical Cancer;American Journal of Clinical Oncology;2018-11

4. A Tf-modified tripterine-loaded coix seed oil microemulsion enhances anti-cervical cancer treatment;International Journal of Nanomedicine;2018-11

5. A randomized phase II/III trial of conventional paclitaxel and carboplatin with or without bevacizumab vs dose-dense paclitaxel and carboplatin with or without bevacizumab, in stage IVB, recurrent or persistent cervical carcinoma: Japan Clinical Oncology Group Study (JCOG1311);Japanese Journal of Clinical Oncology;2018-10-08